Controlled clinical study on efficacy of fixed-dose compounds rifater/rifinah in antituberculous chemotherapy

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Volumn 21, Issue 11, 1998, Pages 645-647

  Zhu, L ^a   Yan, B ^a   Ma, W ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TUBERCULOSIS, PULMONARY;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ISONIAZID; MALE; MIDDLE AGED; PYRAZINAMIDE; RIFAMPIN; TUBERCULOSIS, PULMONARY;

EID: 0032195358     PISSN: 10010939     EISSN: None     Source Type: None    
DOI: None     Document Type: Article

References (0)